Skip to content

Effect of metoprolol on inflammatory markers related to infection in hypertensive intracranial hemorrhage: a randomized double-blinded controlled trial

Effect of metoprolol on inflammatory markers related to infection in hypertensive intracranial hemorrhage: a randomized double-blinded controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022612
Enrollment
Unknown
Registered
2019-04-18
Start date
2019-04-15
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The infection related to hypertensive intracranial hemorrhage

Interventions

Treatment Group:Metoprolol(50mgBID)or combined with other types of antihypertensive drugs
control group:Non-beta-blocking antihypertensive drugs

Sponsors

the First People's Hospital of LongQuanyi District
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Acute onset, the intracranial hemorrhage is confirmed by head CT or MRI. 2. Clear history of hypertension or admission blood pressure >140/100mmHg. 3. Patient informed consent.

Exclusion criteria

Exclusion criteria: 1. The time arriving at hospital after the onset exceed 24 hours. 2. The intracranial hemorrhage caused by non-hypertensive factors is confirmed by CTA or DSA. 3. With a significant history of aspiration,asthma,COPD with acute onset,asthma attacks, and active pulmanary infection confirmed by clinically and laboratory evidence. 4. Requiring antibiotic treatment because of the severe infection. 5. Patients who need surgery or died shortly after admission.

Design outcomes

Primary

MeasureTime frame
PCT;CRP;IL-10;

Secondary

MeasureTime frame
WBC;N%;

Countries

China

Contacts

Public ContactChen Fang

Neurosurgery Department of the First People's Hospital of LongQuanyi District

1491425287@qq.com+86 13881883860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026